Introduction
============

According to clinical guidelines, the definition of non-ST segment elevation myocardial infarction (NSTEMI) is clinical chest tightness and elevation of cardiac enzyme without ST elevation on electrocardiography (ECG) ([@ref-16]). Early percutaneous coronary intervention (PCI) is one of the standard treatments for high-risk NSTEMI patients, including those patients with refractory angina, unstable hemodynamic status, heart failure symptoms, malignant tachyarrhythmia, or a higher risk score ([@ref-16]; [@ref-4]; [@ref-12]; [@ref-22]). The ECG pattern is one of the components of some risk scores used for risk stratification, especially in the mainly pre-thrombolytic and thrombolytic era ([@ref-16]). However, the influence of different ECG patterns on the clinical outcome of NSTEMI is unclear, especially in the PCI era, and the impact of the ECG pattern on risk stratification may be different in the thrombolytic and PCI era. Furthermore, no studies have focused on the impact of ECG patterns on long-term outcomes in this specific population after PCI. This study was aimed at evaluating the prognostic impact of clinical ECG patterns on clinical outcomes of NSTEMI patients undergoing PCI.

Materials & Methods
===================

Setting and patient population
------------------------------

This study retrospectively analyzed all patients who had received PCI after being diagnosed with NSTEMI at Kaohsiung Chang Gung Memorial Hospital from January 2008 to December 2010. Data were collected as previously described in [@ref-23]. Specifically, the definition of NSTEMI was typical chest pain, troponin-I elevation ≥ 0.5 ng/ml and no ST-segment elevation by clinical ECG finding. The inclusion criterion in our study was patients with NSTEMI who received angiography within 72 h after presentation. The exclusion criteria included the availability of only one set of troponin-I data, the absence of a rising pattern of the troponin-I level during follow-up, or delayed PCI (more than 72 h) due to other etiologies (mostly to poor renal function, active bleeding and sepsis). Stent implantations for stenotic vessels were performed according to clinical guidelines  ([@ref-1]). Data collection included baseline characteristics, ECG findings, left ventricular ejection fraction (LVEF) obtained by echocardiography or left ventricular angiography, coronary angiography and PCI data. Blood samples were evaluated when patients arrived at the ER (emergency room), and ECG was performed after the patients arrived, or if they had acute typical chest pain during hospitalization. We analyzed the in-hospital outcomes, including total mortality, cardiac death, ventricular arrhythmia and pulmonary edema. Patients received continued clinical follow-up after being discharged. The primary endpoint of this study was long-term mortality. The secondary endpoint was long-term cardiac death and non-fatal major adverse cardiac events (MACE), which were defined as target vessel revascularization, myocardial infarction (MI), stroke, and hospitalization for heart failure. An advanced Killip score was defined as a score ≥ 3 and advanced chronic kidney disease (CKD) was defined as an estimated glomerular filtrating rate \<60 ml/min/1.73 m2. The study protocol was approved by the Institutional Review Committee for Human Research of Kaohsiung Chang Gung Memorial Hospital (201900344B0). The need for consent was waived by the Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital.

Electrocardiography (ECG) definition
------------------------------------

The ECG findings were classified as no significant ST-T change, ST depression or T wave inversion. ST depression was defined as horizontal or down-sloping ST segment depression ≥1 mV at 80 ms after a J point over at least 2 consecutive leads. T wave inversion was defined as the amplitude of an inverted T wave of at least 1 mm over at least 2 consecutive leads. Patients with 1 mm ST-segment depression and T-wave inversion were classified as having ST depression. ECG results that did not meet these criteria without significant ST segment elevation were defined as showing no significant ST-T change. Those patients who had some ST elevation, but not enough to meet STEMI criteria, were also classified as "no significant ST-T change".

Coronary angiography and stenting
---------------------------------

Coronary stent implantation was performed using procedures and protocols described in our previous publications ([@ref-23]; [@ref-6]; [@ref-7]). Briefly, diagnostic catheterization and intervention were performed as soon as possible within 72 h after the diagnosis of NSTEMI was confirmed. Before the procedure, dual antiplatelets (aspirin and clopidogrel) were given, and unfractionated heparin or low molecular weight heparin was given for heparinization, based on renal function. We did total revascularization for culprit lesions and all other radiographically significant stenoses at the index procedure for those patients presenting with NSTEMI, or treated non-culprit lesions at the staged procedure during the index admission. Left main (LM) lesions with ≥50% stenosis and lesions of the main trunk of triple vessels with more than 70% stenosis were usually treated (stenting if the vascular reference was ≥ 2.5 mm or balloon angioplasty for vascular references of 2.0--2.5 mm). Chronic total occlusive lesions usually did not undergo revascularization during the index procedure. We usually evaluated myocardial perfusion using a thallium-201 scan thereafter, during the OPD follow-up, and decided if revascularization was indicated for those patients. Most lesions were predilated with a 1:1 ratio of balloons prior to stent implantation. Most patients underwent post-stenting dilatation with a high-pressure balloon. Multiple-vessel disease (MVD) was defined as stenosis ≥50% in ≥2 major epicardial coronary arteries.

Post-percutaneous coronary intervention management
--------------------------------------------------

Patients were treated according to current clinical guidelines for post-PCI management ([@ref-23]). Our patients were covered under Taiwan's National Health Insurance (NHI) program, which is a compulsory single-payer healthcare system featuring care coverage for more than 99.8% of the population in Taiwan. In accordance with NHI reimbursement criteria, dual antiplatelet therapies were given for at least 9 months and statin therapy was given for those patients with low-density lipoprotein ≥ 100 mg/dl, in the absence of contraindications. Patients were referred for cardiac rehabilitation routinely and the compliance rate was about 90%. Major risk factors such as smoking, hypertension, dyslipidemia, physical inactivity, obesity, and diabetes mellitus (DM) were also treated.

Statistical analysis
--------------------

Unless otherwise stated, data were expressed as means ± standard deviation or as a number (percentage). Differences in continuous variables were analyzed using one-way analysis of variance for continuous variables, and categorical variables were analyzed using the chi-square test. Pairwise *post hoc* multiple comparisons between any 2 study groups were made using the Bonferroni adjustment. For long-term outcome analysis, those patients with T wave inversion and no significant ST change pattern were defined as the no-ST depression group. The independent predictors of long-term mortality were analyzed using the multiple stepwise Cox regression method. Event-free survival in patients with and without ST depression and also with different ECG patterns was evaluated and compared by the Kaplan--Meier method and log rank test. Statistical analysis was performed with statistical software (SPSS Statistics for Windows, version 17.0; SPSS Inc., Chicago, IL, USA). A 2-tailed *p* value \<0.05 was considered statistically significant.

Results
=======

Baseline characteristics and in-hospital outcomes of the study patients
-----------------------------------------------------------------------

During the study period, 409 patients who had a clinical diagnosis of NSTEMI received coronary angiography and PCI. Forty-seven patients who met our exclusion criteria were excluded from analysis. Of the 362 patients enrolled in this study, 264 (72.9%) were males and the average age was 65.6 ± 12.2 years. Sixty-seven (18.5%) patients were classified as having ST depression, 91 (25.1%) as having T wave inversion, and the remaining 204 (56.4%) as having no significant ST-T change pattern. Patients with ST depression had a significantly higher percentage of DM and CKD than patients with T wave inversion and no significant ST-T changes (both *P* \< .05). More of the patients with ST depression and T wave inversion had a past history of old MI and coronary artery bypass surgery (CABG) than the patients with no significant ST-T changes (both *P* \<0.05). More patients with ST depression had an advanced Killip score, and patients with T wave inversion had a lower body mass index than patients with no significant ST-T change (both *P* \<0.05). There was no significant difference in age, male gender, current smoker, hypertension, dyslipidemia, old stroke, peripheral vascular disease, percutaneous transluminal coronary angioplasty, or time to angiography among patients with different ECG patterns. Patients with ST depression had a higher creatinine level than other patients and a higher troponin-I level than patients with T wave inversion (both *P* \<0.05). There was no significant difference in LVEF among patients with different ECG patterns ([Table 1](#table-1){ref-type="table"}).
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###### Baseline characteristics, angiographic findings and clinical outcomes of 362 study patients according to the presenting ECG.
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  Variables                                                No ST changes (*n* = 204)   Inverted T wave (*n* = 91)   ST depression (*n* = 67)   *P* Value
  -------------------------------------------------------- --------------------------- ---------------------------- -------------------------- -----------
  Age (yrs)                                                64.7 ± 12.2                 65.2 ± 13.4                  68.8 ± 10.3                0.059
  Male gender                                              77.5% (158)                 68.1% (62)                   65.7% (44)                 0.084
  Current smoker                                           24.0% (49)                  28.6% (26)                   17.9% (12)                 0.301
  Hypertension                                             74.5% (152)                 70.3% (64)                   76.1% (51)                 0.669
  Diabetes mellitus                                        46.1% (94)^a^               35.2% (32)^a^                52.2% (35)^b^              0.080
  Dyslipidemia                                             38.7% (79)                  36.3% (33)                   37.3% (25)                 0.918
  Old stroke                                               16.2% (33)                  22.0% (20)                   19.4% (13)                 0.473
  Old MI                                                   8.8% (18)^a^                17.6% (16)^b^                17.9% (12)^b^              0.042
  Advanced CKD[^\*^](#table-1fn3){ref-type="fn"}           40.2% (82)^a^               44.0% (40)^a^                65.7% (44)^b^              \<0.001
  PVD                                                      3.4% (7)                    4.4% (4)                     7.5% (5)                   0.379
  Prior PTCA                                               15.2% (31)                  13.2% (12)                   23.9% (16)                 0.161
  Prior CABG                                               0% (0)^a^                   3.3% (3)^b^                  6.0% (4)^b^                0.005
  BMI (kg/m2)                                              25.4 ± 3.6^a^               24.1 ± 3.4^b^                25.2 ± 3.6^ab^             0.020
  Advanced Killip score[^†^](#table-1fn4){ref-type="fn"}   12.7% (26)^a^               19.8% (18)^ab^               32.8% (22)^b^              0.001
  LVEF (%)                                                 60.7 ± 12.3                 59.3 ± 14.6                  56.2 ± 15.3                0.070
  Creatinine level (mg/dl)                                 1.33 ± 1.07^a^              1.26 ± 0.85^a^               1.87 ± 1.70^b^             0.002
  eGFR (ml/min/1.73m^2^)                                   68.1 ± 28.7^a^              66.6 ± 28.5^a^               51.2 ± 25.3^b^             \<0.001
  Troponin-I (ng/ml)                                       9.88 ± 24.6^ab^             7.4 ± 9.8^b^                 19.4 ± 50.0^a^             0.025
  CAG/PTCA finding                                                                                                                             
  Time to angiography                                                                                                                          0.654
  \<24 h                                                   38.7% (79)                  45.1% (41)                   37.3% (25)                 
  24--48 h                                                 12.7% (26)                  12.1% (11)                   17.9% (12)                 
  48--72 h                                                 48.5% (99)                  42.9% (39)                   44.8% (30)                 
  Significant CAD                                          89.2% (182)                 84.6% (77)                   82.1% (55)                 0.259
  Multiple-vessel disease                                  67.2% (137)                 62.6% (57)                   71.6% (48)                 0.489
  LM                                                       9.8% (20)^a^                12.1% (11)^a^                25.4% (17)^b^              0.005
  Total stent number                                       1.6 ± 1.1                   1.5 ± 1.1                    1.8 ± 1.4                  0.255
  Stent type                                                                                                                                   0.277
  Drug eluting stent                                       45.6% (93)                  48.4% (44)                   34.3% (23)                 
  Bare metal stent                                         43.6% (89)                  37.4% (34)                   47.8% (32)                 
  Final TIMI-3 flow                                        98.0% (200)                 98.9% (90)                   100.0% (67)                0.474
  Complete revascularization                               93.1% (190)                 93.4% (85)                   89.6% (60)                 0.585
  Medication                                                                                                                                   
  Aspirin                                                  81.9% (167)^a^              79.1% (72)^a^                70.1% (47)^b^              0.124
  Clopidogrel                                              89.7% (183)^a^              81.3% (74)^b^                85.1% (57)^ab^             0.132
  ACEI/ARB                                                 70.1% (143)                 64.8% (59)                   61.2% (41)                 0.350
  Beta-blocker                                             63.7% (130)                 68.1% (62)                   56.7% (38)                 0.337
  Statin                                                   56.9% (116)                 54.9% (50)                   56.7% (38)                 0.952
  In-hospital events                                                                                                                           
  Total mortality                                          2.9% (6)^a^                 1.1% (1)^a^                  9.0% (6)^b^                0.024
  Cardiac death                                            2.5 (5)^a^                  0% (0)^a^                    7.5% (5)^b^                0.017
  VT/VF                                                    2.9% (6)                    2.2% (2)                     4.5% (3)                   0.706
  PE                                                       17.2% (35)^a^               18.7% (17)^a^                46.3% (31)^b^              \<0.001
  Long-term outcome                                                                                                                            
  Follow-up duration (months)                              69.7 ± 43.9^a^              72.1 ± 43.8^a^               48.0 ± 41.2^b^             0.001
  Total mortality                                          15.2% (31)^a^               8.8% (8)^a^                  31.3% (21)^b^              0.001
  Cardiac death                                            7.4% (15)^a^                0.0% (0)^b^                  14.9% (10)^c^              0.001
  MACE[^‡^](#table-1fn5){ref-type="fn"}                    31.9% (65)                  35.2% (32)                   32.8% (22)                 0.856
  TVR                                                      14.2% (29)                  12.1% (11)                   13.4% (9)                  0.885
  MI                                                       9.3% (19)                   13.2% (12)                   9.0% (6)                   0.556
  Stroke                                                   4.9% (10)                   5.5% (5)                     4.5% (3)                   0.956
  Heart failure                                            9.8% (20)                   9.9% (9)                     13.4% (9)                  0.686

**Notes.**

Data are expressed as means ± SD or % (n).

ACEI/ARBangiotensin-converting enzyme inhibitors/angiotensin-receptor blockersBMIbody mass indexCABGcoronary artery bypass surgeryCAGcoronary angiographyECGelectrocardiogrameGFRestimated glomerular filtration rateESRDend stage renal diseaseHFheart failureLVEFleft ventricular ejection fractionMACEmajor adverse cardiac eventMImyocardial infarctionPCIpercutaneous cardiac interventionPEpulmonary edemaPTCApercutaneous transluminal coronary angioplastyPVDperipheral vascular diseaseTIMIthrombolysis in myocardial infarctionTVRtarget vessel revascularizationVFventricular fibrillationVTventricular tachycardia

eGFR \< 60 ml/min/1.73 m^2^.

Killip score ≥ 3.

Target vessel revascularization, myocardial infarction, stroke and hospitalization for heart failure.

Different letters (a, b, c, i.e.,^a^ vs. ^b^, vs.^c^) indicate significant difference between groups (*P* \< 0.05).

Total revascularization for culprit lesions and all other radiographically significant stenoses were achieved in 95.6% of patients during hospitalization (93.8% at the index procedure simultaneously for those patients presenting with NSTEMI and 1.8% at the staged procedure for non-culprit lesions during the index admission.) In terms of coronary angiography and PCI findings, more patients presenting with ST depression had left main disease than patients presenting with other ECG findings (*P* \<0.05). There was no difference in the percentage of significant coronary artery disease (CAD), MVD, total stents number and types and post-PCI final thrombolysis in MI (TIMI)-3 flow among patients with different ECG patterns. Patients presenting with an ST depression pattern had more total in-hospital mortality, cardiac death and pulmonary edema events (*P* \<0.05). The number of events of in-hospital ventricular tachycardia and fibrillation did not differ.

Primary outcome analysis: long-term mortality
---------------------------------------------

The mean follow-up period was 66.3 ± 44.1 months: 60 (16.6%) patients died during that period. Total mortality was significantly higher among patients with ST depression than among those with T wave inversion and no significant ST-T change (*P* = 0.001) ([Table 1](#table-1){ref-type="table"}).

Compared to the patients who survived, those who had died were significantly older (71.4 ± 9.4 vs. 64.4 ± 12.4 years, *p* \< 0.001), and more likely to have DM, prior percutaneous transluminal coronary angioplasty (PTCA), advanced CKD, advanced Killip score and lower LVEF (all *p* \< .05). Those patients who died were also more likely to have an ECG pattern of ST depression than the patients who survived (35.0 vs. 15.2%, *p* \< 0.001) ([Table 2](#table-2){ref-type="table"}). All variables with a *P* value ≤ 0.1 by univariate analysis were put into multiple stepwise Cox regression analysis, which showed that advanced Killip score (hazard ratio \[HR\] = 3.417, 95% confidence interval (CI): 1.966--5.939, *P* \<0.001), age (HR = 1.043, 95% CI \[1.015--1.072\], *P* = 0.002), prior PTCA (HR = 1.987, 95% CI \[1.110--3.558\], *P* = 0.021), advanced CKD (HR = 1.871, 95% CI \[1.044--3.354\], *P* = 0.035) and ECG pattern of ST depression (HR = 1.809, 95% CI \[1.015--3.223\], *P* = 0.044) were the only independent predictors of long-term mortality ([Table 3](#table-3){ref-type="table"}).

[Figure 1A](#fig-1){ref-type="fig"} compares the Kaplan--Meier curves for primary endpoint among patients with and patients without an ECG pattern of ST depression. Long-term mortality was significantly higher in patients with ST depression than in those without ST depression (Log-rank *p* value \<0.001). [Figure 1B](#fig-1){ref-type="fig"} compares the Kaplan--Meier curves for primary endpoint among patients with different ECG patterns. Patients with ST depression were found to have a higher rate of long-term mortality than patients with T wave inversion and no significant ST-T changes (Log-rank *p* value \<0.001).

Secondary endpoint analysis: long-term cardiac death and non-fatal MACE
-----------------------------------------------------------------------

Long-term cardiac death was significantly higher in patients with an ST depression ECG pattern than in patients with T wave inversion and no significant ST change pattern (*P* = 0.001) ([Table 1](#table-1){ref-type="table"}). There was no difference in long-term non-fatal MACE among patients with different ECG patterns. The cardiac death rate was significantly higher in patients with an ST depression ECG pattern than in those without ST depression ([Fig. 2A](#fig-2){ref-type="fig"}; Log-rank *p* value = 0.001). In [Fig. 2B](#fig-2){ref-type="fig"}, a comparison of Kaplan--Meier curves for cardiac death among patients with different ECG patterns revealed that patients with ST depression had a higher rate of long-term cardiac death than patients with T wave inversion and no significant ST-T changes (Log-rank *p* value \<0.001). Kaplan--Meier curves for non-fatal MACE among patients with and without an ST depression ECG patterns revealed that there was no difference in both groups (Log-rank *P* value = 0.228) ([Fig. 3A](#fig-3){ref-type="fig"}). There was no difference in non-fatal MACE among patients with ST depression, no significant ST-T changes and T wave inversion (Log-rank *P* value = 0.482) ([Fig. 3B](#fig-3){ref-type="fig"}).

Discussion
==========

There are several important findings in this study. First, NSTEMI patients presenting with an ST depression ECG pattern had a higher percentage of DM, advanced CKD and LM disease than those patients presenting with other ECG patterns. Second, the NSTEMI patients presenting with an ST depression ECG pattern had not only higher rates of in-hospital total mortality, cardiac death and pulmonary edema but also higher rates of total mortality and cardiac death during long-term follow-up. Third, an advanced Killip score, older age, advanced CKD, prior PTCA and an ST depression ECG pattern were independent predictors of long-term total mortality.
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###### Baseline characteristics, angiographic findings and clinical outcomes of 362 study patients with and without long term mortality.
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  Variables                                               Mortality (*n* = 60)   Alive (*n* = 302)   *P* Value
  ------------------------------------------------------- ---------------------- ------------------- -----------
  Age (yrs)                                               71.4 ± 9.4             64.4 ± 12.4         \<0.001
  Male gender                                             65.0% (39)             74.5% (225)         0.130
  Current smoker                                          16.7% (10)             25.5% (77)          0.185
  Hypertension                                            78.3% (47)             72.8% (220)         0.425
  Diabetes mellitus                                       60.0% (36)             41.4% (125)         0.010
  Dyslipidemia                                            38.3% (23)             37.7% (114)         0.932
  Old stroke                                              23.3% (14)             17.2% (52)          0.263
  Old myocardial infarction                               13.3% (8)              12.6% (38)          0.873
  Prior PTCA                                              28.3% (17)             13.9% (42)          0.006
  Prior CABG                                              1.7% (1)               2.0% (6)            1.000
  Peripheral vascular disease                             8.3% (5)               3.6% (11)           0.106
  Advanced CKD[^a^](#table-2fn3){ref-type="fn"}           66.7% (40)             41.7% (126)         0.001
  Body mass index (kg/m^2^)                               25.1 ± 3.8             25.0 ± 3.5          0.932
  Advance Killip score[^b^](#table-2fn4){ref-type="fn"}   43.3% (26)             13.2% (40)          \<0.001
  Troponin-I                                              19.6 ± 52.5            9.3 ± 21.2          0.137
  LVEF                                                    54.5 ± 13.9            60.5 ± 13.5         0.003
  Time to angiography                                                                                0.177
  \<24 h                                                  30.0% (18)             42.1% (127)         
  24--48 h                                                18.3% (11)             12.6% (38)          
  48--72 h                                                51.7% (31)             45.4% (137)         
  ECG changes                                                                                        \<0.001
  ST depression                                           35.0% (21)             15.2% (46)          
  No ST depression                                        65.0% (39)             84.8% (256)         
  Multiple-vessel disease                                 66.7% (40)             66.9% (202)         0.974
  Left main disease                                       20.0% (12)             11.9% (36)          0.092
  Total stent number                                      1.4 ± 1.0              1.3 ± 0.7           0.326
  Stent type                                                                                         0.407
  Drug eluting stent                                      36.7% (22)             45.7% (138)         
  Bare metal stent                                        50.0% (30)             41.4% (125)         
  Post-PCI TIMI-3 flow                                    96.7% (58)             99.0% (299)         0.156
  Complete revascularization                              91.7% (55)             92.7% (280)         0.778

**Notes.**

Data are expressed as means ± SD or % (n).

CABGcoronary artery bypass surgeryCKDchronic kidney diseaseECGelectrocardiogramESRDend stage renal diseaseLVEFLeft Ventricular Ejection fractionPCIpercutaneous cardiac interventionPTCApercutaneous transluminal coronary angioplastyTIMIThrombolysis in Myocardial Infarction

Estimated glomerular filtration rate \< 60 ml/min/1.73 m^2^.

Killip score ≥ 3.
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###### Univariate and multivariate analysis of predictors for long-term mortality.
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  Variables                                                Univariate analysis    Multivariate analysis                          
  -------------------------------------------------------- ---------------------- ----------------------- ---------------------- ---------
  Advanced Killip score[^a^](#table-3fn2){ref-type="fn"}   5.436 (3.232--9.143)   \<0.001                 3.417 (1.966--5.939)   \<0.001
  Age (year)                                               1.065 (1.039--1.093)   \<0.001                 1.043 (1.015--1.072)   0.002
  Prior PTCA                                               2.443 (1.391--4.293)   0.002                   1.987 (1.110--3.558)   0.021
  Advanced CKD[^b^](#table-3fn3){ref-type="fn"}            2.782 (1.670--4.636)   \<0.001                 1.871 (1.044--3.354)   0.035
  ST depression                                            3.113 (1.826--5.308)   \<0.001                 1.809 (1.015--3.223)   0.044
  LM disease                                               2.516 (1.326--4.775)   0.005                   1.919 (1.069--3.445)   0.094
  DM                                                       2.067 (1.232--3.467)   0.006                   1.083 (0.611--1.922)   0.784
  LVEF (%)                                                 0.967 (0.950--0.985)   \<0.001                 1.002 (0.981--1.023)   0.868

**Notes.**

CIconfidence intervalCKDchronic kidney diseaseDMdiabetes mellitusHRhazard ratioLMleft mainLVEFleft ventricular ejection fractionPTCApercutaneous transluminal coronary angioplasty

Killip score ≥ 3.

Estimated glomerular filtration rate \< 60 ml/min/1.73 m^2^.

![Kaplan--Meier estimates of total mortality among patients with different ST segment morphology on the presenting electrocardiography.\
(A) Kaplan--Meier estimates of total mortality among patients with and without ST depression on the presenting electrocardiography. The analysis reveals that the overall survival rate at 66 months was significantly lower in the ST depression group than in the no-ST depression group (69.7% versus 88.5%, Log-rank *P* value \< 0.001). (B) Kaplan--Meier estimates of total mortality among patients with no significant ST-T change, ST depression and T wave inversion on presenting electrocardiography. The analysis reveals that the overall survival rate at 66 months was significantly lower in the ST depression group than in the no significant ST-T change and T wave inversion group (69.7% versus 87.4% versus 91.0%, Log-rank *P* value \< 0.001).](peerj-08-8796-g001){#fig-1}

![Kaplan--Meier estimates of cardiac death among patients with different ST segment morphology on the presenting electrocardiography.\
(A) Kaplan--Meier estimates of cardiac death among patients with and without ST depression on the presenting electrocardiography. The analysis reveals that the freedom from cardiac death rate at 66 months was significantly lower in the ST depression group than in the no-ST depression group (87.4% versus 95.1%, Log-rank *P* value =0.001). (B) Kaplan--Meier estimates of cardiac death among patients with no significant ST-T change, ST depression and T wave inversion on the presenting electrocardiography. The analysis reveals that the freedom from cardiac death rate at 66 months was significantly lower in the ST depression group than in the no significant ST-T change and T wave inversion group (87.4% versus 93.0% versus 100%, Log-rank *P* value \< 0.001).](peerj-08-8796-g002){#fig-2}

![Kaplan--Meier estimates of non-fatal major adverse cardiac events (MACE) among patients with different ST segment morphology on the presenting electrocardiography.\
(A) Kaplan--Meier estimates of non-fatal MACE, which were defined as target vessel revascularization, myocardial infarction, stroke, and hospitalization for heart failure, among patients with and without ST depression on the presenting electrocardiography. The analysis illustrates that there was no difference in the freedom from non-fatal MACE rate at 66 months among patients with ST depression and no-ST depression ECG patterns (61.7% versus 65.6%, Log-rank *P* value =0.228). (B) Kaplan--Meier estimates of non-fatal MACE among patients with no significant ST-T change, ST depression and T wave inversion on the presenting electrocardiography. The analysis reveals that there were no differences in non-fatal MACE among patients with ST depression, no significant ST-T changes and T wave inversion (61.7% versus 64.9% versus 67.2%, Log-rank *P* value = 0.482).](peerj-08-8796-g003){#fig-3}

An ST depression ECG pattern is one of the components of the TIMI risk score commonly used to predict 14-day outcomes of unstable angina and NSTEMI in clinical practice ([@ref-2]). It is surprising that only a few studies have compared intermediate or long-term (using only 6--60 months of mean follow-up time) outcomes of acute coronary syndrome (ACS)/NSTEMI between patients with and without ST depression in the mainly pre-thrombolytic and thrombolytic era ([@ref-3]; [@ref-13]; [@ref-9]; [@ref-14]). To the best of our knowledge, this is the only study to compare the long-term outcome of NSTEMI patients with and without ST depression in the intervention era. The TIMI III Registry showed that in patients with non-ST elevation ACS, an ST deviation of as little as 0.05 mV increased the risk of death or MI by approximately 2-fold, both at 30 days and at 1 year ([@ref-3]). [@ref-13] reported that ST depression of 0.05 mV or more on the admission ECG was related to 4-year mortality rates; the risk of death increased as ST depression increased. In contrast, T-wave inversion of 0.1 mV or more was associated with only a modest increase or no increase at all in the subsequent risk of death or MI in the same study ([@ref-13]). In that study, 67% of patients received intravenous heparin, 37% underwent angiography, and 35% underwent revascularization. Researchers with the GRACE study (Global Registry of Acute Coronary Events) developed a score that allows us to predict patient mortality 6 months after being discharged following an ACS episode; an ST decrease ≥ 1 mm was one of 9 prognostic variables used to determine the patient's probability of death ([@ref-9]). It is worth noting that 33% of patients received PCI or CABG in this study, and having no in-hospital PCI was another predictor of 6-month mortality. The PREDICT score is the only score developed to predict a relatively long-term prognosis (6 years) after hospitalization for ACS in the mainly pre-thrombolytic and thrombolytic era ([@ref-14]). Only 11% of patients received thrombolytic therapy in the study. ST segment depression \>1 mm horizontal or downward sloping was a major predictor of long-term mortality in this score. Our study was conducted in the PCI era and all patients received angiography; 87% of these patients received PCI due to significant CAD. ST depression is still an independent predictor of in-hospital and long-term mortality. Our study confirms the previous finding that only those patients with an ST depression pattern, but not with T wave inversion, had a worse in-hospital and long-term mortality (more than 5 years) outcome than patients with no significant ST-T changes. An ST depression ECG pattern may be a very easy and important hint for clinical physicians to use to identify those NSTEMI patients who are at higher risk of in-hospital and long-term mortality. Patients with ST depression may need more aggressive therapy and management, including risk modification and even immediate or early intervention (for those patients with refractory angina, unstable hemodynamic status, heart failure symptoms, malignant tachyarrhythmia, or a higher TIMI or GRACE risk score, according to clinical guidelines). Further studies focusing on the role of an ST depression ECG pattern in risk stratification and the impact of immediate or early intervention on outcomes are needed for further evaluation.

A previous study showed a T-wave inversion is sensitive for ischemia but is less specific, unless it is marked (≥0.3 mV) ([@ref-13]). This may explain why T-wave inversion could not independently predict total mortality in previous studies and in our study.

Furthermore, our study showed that the percentages of DM, advanced CKD and LM disease were higher in patients with ST depression than in patients with other ECG patterns. A consistent finding was that the risk of adverse outcomes increased with diabetes, impaired renal function and prior CAD during ACS ([@ref-23]; [@ref-14]; [@ref-8]; [@ref-10]; [@ref-19]; [@ref-11]; [@ref-15]). Among patients with CAD, LM disease was not only a strong predictor of in-hospital mortality for PCI, but was also associated with high mortality, even after successful PCI for ACS ([@ref-25]; [@ref-17]). These findings may explain why patients with an ST depression ECG pattern in our study had worse in-hospital and long-term clinical outcomes. Our study also confirms previous findings that advanced Killip score, old age, prior PTCA and advanced CKD are strong predictors of a long-term adverse outcome ([@ref-15]; [@ref-5]; [@ref-21]; [@ref-18]).

Study limitations
-----------------

Some limitations in this study should be noted. First, this was a retrospective cohort study. Second, this study did not include in the analysis NSTEMI patients who received conservative therapy. Therefore, this study might have selection bias. However, the clinical outcome was better in those patients who received in-hospital PCI compared with those patients who received conservative therapy, as reported in previous studies ([@ref-10]; [@ref-24]; [@ref-20]). All of our patients with significant CAD received PCI during hospitalization, and ST depression was still a strong predictor of long-term mortality and cardiac death.

Conclusions
===========

Our study findings suggest that among NSTEMI patients undergoing PCI, those presenting with an ST depression ECG pattern had a higher percentage of DM, advanced CKD and LM disease than patients without ST depression. Long-term outcomes, especially in terms of total mortality and cardiac death, were worse in patients with an ST depression ECG pattern than in patients without ST depression; this may be due to associated comorbidities.
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